Glass House Brands (GLAS) EPS (Basic) Growth (3y) (2023 - 2026)
Glass House Brands (GLAS) EPS (Basic) Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.11 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.11 Bn | 39.45 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 3.18% |
| 4 | Takeda Pharmaceutical | 28.53 Bn | 22.73 Bn | 5.10 Bn | 2.42% |
| 5 | United Therapeutics | 22.47 Bn | 19.81 Bn | 683.80 Mn | 12.25% |
| 6 | Viatris | 18.66 Bn | 17.77 Bn | 1.46 Bn | -35.06% |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 13.47% |
| 8 | Elanco Animal Health | 11.98 Bn | 11.45 Bn | 798.00 Mn | 36.60% |
| 9 | Dr Reddys Laboratories | 10.08 Bn | 9.91 Bn | - | - |
| 10 | Glass House Brands | 842.00 Mn | 823.45 Mn | 15.77 Mn | 48.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.68% |
| Dec 31, 2025 | 25.66% |
| Sep 30, 2025 | -35.80% |
| Jun 30, 2025 | 25.99% |
| Mar 31, 2025 | 27.33% |
| Sep 30, 2024 | 25.99% |
| Jun 30, 2024 | 25.99% |
| Mar 31, 2024 | 27.00% |
| Dec 31, 2023 | 99.19% |
| Sep 30, 2023 | 57.54% |
| Mar 31, 2023 | 5.28% |